Search
Search Results
-
Long-term endoscopic gastric mucosal changes up to 20 years after Helicobacter pylori eradication therapy
Helicobacter pylori eradication therapy reduces the risk of gastric cancer. However, it is unclear whether the severity of risk factors for gastric...
-
Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection
To assess the effectiveness and safety of combining Saccharomyces boulardii powder with triple therapy as a primary approach for eradicating H. pylori ...
-
Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial)
Potassium-competitive acid blockers (P-CABs) provide potent acid inhibition, yet studies on P-CAB-based quadruple therapy for H. pylori eradication...
-
Association between failed eradication of 7-day triple therapy for Helicobacter pylori and untreated dental caries in Japanese adults
Helicobacter pylori ( H. pylori ) infection is a cause of gastric disorders and is treated mainly by pharmacotherapy with antimicrobial agents. An...
-
Selective haematological cancer eradication with preserved haematopoiesis
Haematopoietic stem cell (HSC) transplantation (HSCT) is the only curative treatment for a broad range of haematological malignancies, but the...
-
Usefulness of texture and color enhancement imaging (TXI) in early gastric cancer found after Helicobacter pylori eradication
Early-stage gastric cancer (EGC) found after Helicobacter pylori (Hp) eradication is often difficult to diagnose using conventional white light (WL)...
-
Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial
Previous studies have suggested that Helicobacter pylori ( H. pylori ) infection is associated with nonalcoholic fatty liver disease (NAFLD). The...
-
Compositions of gut microbiota before and shortly after hepatitis C viral eradication by direct antiviral agents
It is unclear whether dysbiosis in hepatitis C virus (HCV) infected patients results from the viral infection per se or develops as a result of...
-
Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study
Currently, it is unclear whether treating Helicobacter pylori ( H. pylori ) infection is safe among adolescents. This study aimed to evaluate the...
-
Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori
Transient gut microbiota alterations have been reported after antibiotic therapy for Helicobacter pylori . However, alteration in the gut virome after H...
-
Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis
We previously demonstrated that P. aeruginosa isolates that persisted in children with cystic fibrosis (CF) despite inhaled tobramycin treatment had...
-
Changes in the gut microbiota after hepatitis C virus eradication
The gut microbiota interacts with infectious diseases and affects host immunity. Liver disease is also reportedly associated with changes in the gut...
-
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China
The eradication rate of Helicobacter pylori ( H. pylori ) has been decreasing every year, mainly due to the increase in antibiotic resistance. In fact,...
-
Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
We prospectively investigated the changes of liver stiffness (LS) and the occurrence of hepatocellular carcinoma (HCC) after hepatitis C virus (HCV)...
-
Reliability of self-reported questionnaire for epidemiological investigation of Helicobacter pylori eradication in a population-based cohort study
General population-based cohort studies provide solid evidence on mass Helicobacter pylori (HP) eradication effects. Self-reported questionnaires are...
-
Real-time monitoring of mono- and dual-species biofilm formation and eradication using microfluidic platform
In a human host, bacterial Staphylococcus aureus and fungal Candida albicans pathogens form a mixed biofilm that causes severe mortality and...
-
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
Liver stiffness measurement (LSM) is a useful tool for assessing advanced liver fibrosis, an important risk factor for hepatocellular carcinoma (HCC)...
-
Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals
We aimed to evaluate factors associated with changes in skeletal muscle mass in hepatitis C virus (HCV)-infected patients after treatment with...
-
Utilization trends for endoscopic ablation therapy and esophagectomy in Barrett’s esophagus from 2005 to 2019
Guidelines have shifted to now recommend endoscopic eradication therapy for Barrett’s esophagus (BE) with low and high-grade dysplasia. Previously,...
-
Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections
Development of an effective therapy to overcome colistin resistance in Klebsiella pneumoniae , a common pathogen causing catheter-related biofilm...
